Through verification of the CGGA data set, TCGA‐LGG data set and clinical samples, we found that the expression of ASPM mRNA increased with the increase of glioma grade, and the high expression of ASPM predicted worse prognosis, suggesting that ASPM may function as a molecular marker for the diagnosis and prognosis prediction of glioma patients. Here, ASPM is linked to central nervous system cancer.